The topoisomerase II
![](/images/gifchars/alpha.gif)
promoter is regulated through transcription factor interactions withfive inverted CCAAT boxes (ICBs). In confluent cancer cells, binding of nuclear factor Y to ICB2 repressesthe expression of this gene, contributing to resistance to topoisomerase II poisons. The ICB sites withinthe topoisomerase II
![](/images/gifchars/alpha.gif)
promoter are, therefore, potential targets for the design of anticancer drugs andgene control agents. The synthesis and DNA binding properties of a hairpin polyamide molecule (
JH-37)that targets 5'-TTGGT-3' found in ICB2 and ICB3 sites are described. Gel shift and DNase I footprintingstudies on the topoisomerase II
![](/images/gifchars/alpha.gif)
promoter showed
JH-37 to preferentially bind to ICB2,3 and ICB1sites. The larger
TM values for ICB2,3 (8-9
![](/images/entities/deg.gif)
C) over ICB1,4,5 (4-5
![](/images/entities/deg.gif)
C) indicated a preference of
JH-37 for ICB2,3. CD titration studies confirmed the binding of
JH-37 to the minor groove, with a 1:1binding stoichiometry. Results from SPR studies showed
JH-37 to bind most strongly to ICB2 (
K = 3 ×10
7 M
-1), followed by ICB1, the non-ICB sequence (TGCA), and finally the ICB mutant (ICB2m). Theimproved binding to ICB2 is largely due to a lower dissociation rate of the compound at the preferredsite. To our knowledge, this is the first example on the use of SPR for studying the interactions of hairpinpolyamides with DNA. Binding of
JH-37 to ICB2 was corroborated by ITC studies, in which the
G![](/images/entities/deg.gif)
of binding is driven by both enthalpy and entropy. With knowledge of the fundamental thermodynamicand kinetic properties that govern the molecular recognition of polyamides with DNA, we are poised tosystematically edit the structure of
JH-37 in order to further enhance its binding affinity and selectivityfor ICB2,3. Our strategy for designing molecules that control gene expression is to target shorter, butmultiple, binding sites that are in close array within the promoter. Binding of
JH-37 to multiple ICB sitesin the topoisomerase II
![](/images/gifchars/alpha.gif)
promoter is an ideal test for this strategy. This approach is in contrast to thetraditional strategy of targeting 15-16 base pairs, which has not been successful in actual biologicalsystems due to poor cell uptake and distribution.